ADAGE CAPITAL PARTNERS GP, L.L.C. - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$435,000
-35.5%
1,500,0000.0%0.00%
-50.0%
Q4 2022$674,850
-14.5%
1,500,0000.0%0.00%0.0%
Q3 2022$789,000
+4.1%
1,500,0000.0%0.00%0.0%
Q2 2022$758,000
-84.0%
1,500,000
+50.0%
0.00%
-77.8%
Q4 2021$4,750,000
-82.9%
1,000,000
-71.4%
0.01%
-83.6%
Q3 2021$27,825,000
+31.1%
3,500,000
+14.8%
0.06%
+31.0%
Q2 2021$21,225,000
-9.1%
3,049,581
+3.4%
0.04%
-12.5%
Q1 2021$23,349,000
-0.8%
2,948,141
-1.5%
0.05%
-5.9%
Q4 2020$23,547,000
+11.0%
2,992,0000.0%0.05%
-3.8%
Q3 2020$21,213,000
-20.7%
2,992,000
+3.5%
0.05%
-22.1%
Q2 2020$26,751,000
+290.9%
2,892,000
+96.9%
0.07%
+240.0%
Q1 2020$6,844,000
-39.0%
1,468,5910.0%0.02%
-28.6%
Q4 2019$11,220,000
-0.6%
1,468,5910.0%0.03%0.0%
Q3 2019$11,293,000
+12.3%
1,468,5910.0%0.03%
+12.0%
Q2 2019$10,060,000
-14.9%
1,468,5910.0%0.02%
-16.7%
Q1 2019$11,822,000
+8.2%
1,468,591
+0.7%
0.03%0.0%
Q4 2018$10,925,000
+24.7%
1,458,591
+59.3%
0.03%
+50.0%
Q3 2018$8,763,000
-7.0%
915,702
+2.8%
0.02%
-9.1%
Q2 2018$9,424,000
+280.0%
890,702
+256.3%
0.02%
+266.7%
Q1 2018$2,480,000250,0000.01%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 340,679$3,604,0001.39%
Nantahala Capital Management 2,213,052$23,414,0000.95%
SCP Investment, LP 156,137$1,652,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 509,118$5,386,0000.74%
DELTEC ASSET MANAGEMENT LLC 151,781$1,606,0000.32%
Rock Springs Capital Management LP 650,000$6,877,0000.26%
Orbimed Advisors 1,865,524$19,737,0000.24%
Baker Brothers Advisors 1,387,872$14,684,0000.11%
EAM Investors, LLC 56,726$600,0000.10%
Stanley-Laman Group, Ltd. 35,036$371,0000.08%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders